Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Nov. 30, 2022	Nov. 30, 2021
Cash used in operating activities:
Net loss	$ (127,429)	$ (28,807)
Adjustments for:
Deferred income tax recovery	(12,941)	(11,228)
Unrealized foreign exchange loss	2,261	(6,530)
Amortization	67,387	76,804
Loss on sale of capital assets	2,208	230
Inventory valuation write down	0	12,000
Other non-cash items	8,177	3,739
Stock-based compensation	20,136	17,670
Loss on long-term investments & equity investments	1,918	2,197
Loss (gain) on derivative instruments	18,997	(133,436)
Change in fair value of contingent consideration	211	1,682
Change in non-cash working capital:
Accounts receivable	6,690	2,734
Prepaids and other current assets	(7,780)	(6,299)
Inventory	5,046	3,409
Accounts payable and accrued liabilities	(1,941)	(44,513)
Net cash used in operating activities	(17,060)	(110,348)
Cash used in investing activities:
Investment in capital and intangible assets	(7,537)	(23,856)
Proceeds from disposal of capital and intangible assets	2,160	8,264
Purchase of marketable securities	(243,186)	0
Net cash paid for business acquisition	(24,372)	0
Net cash used in investing activities	(272,935)	(15,592)
Cash provided by (used in) financing activities:
Share capital issued, net of cash issuance costs	129,593	0
Shares effectively repurchased for employee withholding tax	(1,189)	(3,927)
Proceeds from long-term debt	1,288	0
Repayment of long-term debt and convertible debt	(59,395)	(20,779)
Repayment of lease liabilities	(1,114)	(3,360)
Net (decrease) increase in bank indebtedness	(2,819)	19
Net cash provided by (used in) financing activities	66,364	(28,047)
Effect of foreign exchange on cash and cash equivalents	(2,060)	(2,696)
Net increase (decrease) in cash and cash equivalents	(225,691)	(156,683)
Cash and cash equivalents, beginning of period	415,909	488,466
Cash and cash equivalents, end of period	$ 190,218	$ 331,783